K
Originally published by KBC County NewsFebruary 12, 2026
1mo ago
New Ndovu study seeks solutions for HIV patients failing Dolutegravir treatment
A new multi-country study is generating critical evidence to guide the optimal management of HIV patients who are failing treatment and developing resistance to the drug dolutegravir, offering hope to millions of HIV-positive individuals across Africa and worldwide. HIV is treate..
✨ Key Highlights
A new multi-country study, the Ndovu project, is generating crucial evidence to guide the management of HIV patients failing Dolutegravir (DTG) treatment, a significant concern as DTG is a core component of most HIV regimens in Africa and globally. This initiative aims to address treatment failure, drug resistance, and adherence issues, offering hope to millions.
- The Ndovu project is a large multi-country study being carried out in Kenya, Tanzania, Lesotho, and Mozambique.
- The study is sponsored by the Centre for Epidemiological Modelling and Analysis (CEMA) at the University of Nairobi and funded by the Bill & Melinda Gates Foundation.
- Chief Investigator of the Ndovu Study Dr. Loice Ombajo emphasized the urgent need for evidence to guide patient management when treatment fails due to non-adherence or drug resistance.
Continue Reading
Read the complete article from KBC County News
Advertisement
Related News
Advertisement